Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: withholding or continuing perioperative metformin. Responses to Br J Anaesth 2026; 137: 1280–1 and Br J Anaesth 2026; 137: 1282–3
Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: withholding or continuing perioperative metformin. Responses to Br J Anaesth 2026; 137: 1280–1 and Br J Anaesth 2026; 137: 1282–3. // British Journal of Anaesthesia. – URL: https://www.sciencedirect.com/science/article/pii/S0007091226008093?dgcid=rss_sd_all
Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: withholding or continuing perioperative metformin. Responses to Br J Anaesth 2026; 137: 1280–1 and Br J Anaesth 2026; 137: 1282–3. British Journal of Anaesthesia. https://www.sciencedirect.com/science/article/pii/S0007091226008093?dgcid=rss_sd_all
“Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: withholding or continuing perioperative metformin. Responses to Br J Anaesth 2026; 137: 1280–1 and Br J Anaesth 2026; 137: 1282–3.” British Journal of Anaesthesia.
@article{article38917,
title = {Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: withholding or continuing perioperative metformin. Responses to Br J Anaesth 2026; 137: 1280–1 and Br J Anaesth 2026; 137: 1282–3},
journal = {British Journal of Anaesthesia},
url = {https://www.sciencedirect.com/science/article/pii/S0007091226008093?dgcid=rss_sd_all}
}
ABSTRACT Background For half the world's population, headaches represent a major health burden that cripples productivity and mental well‐being. While newer CGRP‐targeted drugs have shown promise for migraines, less is known about how...